Mediterranean Journal of Nutrition and Metabolism

, Volume 1, Issue 3, pp 145–148

New nutritional approach to inflammatory bowel disease: the nutraceuticals

  • Marina Taus
  • Debora Busni
  • Massimiliano D. Petrelli
  • Albano Nicolai
Review

DOI: 10.1007/s12349-008-0022-3

Cite this article as:
Taus, M., Busni, D., Petrelli, M.D. et al. Mediterr J Nutr Metab (2009) 1: 145. doi:10.1007/s12349-008-0022-3
  • 62 Downloads

Abstract

The clinical course of inflammatory bowel disease (IBD) is characterised by periods of quiescent disease interspersed with episodes of active inflammation; consequently, malabsorption and malnutrition are the most important problems in IBD patients. It has been widely demonstrated that nutritional support allows more tolerability both to drugs and surgery therapy increases the duration of remission. Among enteral formula enriched in specific nutraceuticals like glutamine or transforming growth factor β2 used in IBD, we tested those enriched with omega 3, soluble fibre and arginine. We observed a high compliance and a statistically significant improvement of symptoms, nutritional status, inflammatory index and Crohn’s disease activity index. A specific nutritional intervention, in particular specific enteral nutrition formula, is essential in the prevention and treatment of malnutrition caused by IBD.

Key words

Inflammatory bowel disease Enteral nutrition Nutraceuticals Artificial nutrition 

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Marina Taus
    • 1
  • Debora Busni
    • 1
  • Massimiliano D. Petrelli
    • 1
  • Albano Nicolai
    • 1
  1. 1.SOD di Dietetica e Nutrizione ClinicaAOU Ospedali Riuniti AnconaAnconaItaly